This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access
by Zacks Equity Research
Illumina (ILMN) signs agreement to expand the availability of WGS to enable faster and cost-effective diagnosis of genetic diseases in children.
4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021
by Trina Mukherjee
Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.
The Zacks Analyst Blog Highlights: L Brands, Deere & Co, IPG Photonics, PerkinElmer and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: L Brands, Deere & Co, IPG Photonics, PerkinElmer and Hologic
QIAGEN (QGEN) Launches RUO Solution to Explore Immune Response
by Zacks Equity Research
QIAGEN's (QGEN) latest RUO solution is expected to provide better insights into the course of the COVID-19 infection and aid in vaccine development and deployment.
LabCorp (LH) Covance Arms Shows Momentum Amid COVID-19 Woes
by Zacks Equity Research
In oncology too, LabCorp (LH) receives a significant award to be the partner of choice for late-stage oncology studies from a major pharmaceutical company.
NuVasive (NUVA) Focuses on Cervical Spine Portfolio Expansion
by Zacks Equity Research
The ACP system within NuVasive (NUVA) C360 is targeted to reduce common postoperative complications such as dysphagia, malalignment and adjacent level ossification.
Top Ranked Growth Stocks to Buy for December 8th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 8th
Here's Why You Should Hold on to Globus Medical (GMED) for Now
by Zacks Equity Research
Investors continue to be optimistic about Globus Medical (GMED) on robust product uptake and prominent sales trend improvement in the third quarter.
The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific
CVS Health (CVS) 2021 Selling Season Strong, LTC Arm Suffers
by Zacks Equity Research
Since the start of the pandemic, CVS Health (CVS) is seeing more than 40% of all specialty orders being placed digitally.
Boston Scientific's (BSX) SCS Systems Receives FDA's Nod
by Zacks Equity Research
Boston Scientific's (BSX) WaveWriter Alpha portfolio of SCS Systems aims to widen the therapy options available for managing chronic pain.
6 S&P 500 Must-Buy Stocks for 2021 Flying High Amid Pandemic
by Nalak Das
It will be prudent to invest in Zacks top-Ranked S&P 500 stocks that have skyrocketed year to date with strong potential for 2021. These include DE, HOLX, LB, PKI, IPGP, QRVO.
Hologic (HOLX) Down 5.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Growth Stocks to Tap the COVID-Driven Shift in MedTech
by Urmimala Biswas
To beat the pandemic blues and maximize capital gains, investors can now scoop up these fundamentally-strong MedTech growth stocks.
Abbott's (ABT) Libre 2 Cleared in Canada, Boosts CGM Prospects
by Zacks Equity Research
Abbott's (ABT) next-generation FreeStyle Libre 2 system aims to provide a better quality of life to diabetics in Canada at the same affordable price of the current FreeStyle Libre system.
Zacks.com featured highlights include: Activision Blizzard, Brinker International, Five Below, Hologic and Owens Corning
by Zacks Equity Research
Zacks.com featured highlights include: Activision Blizzard, Brinker International, Five Below, Hologic and Owens Corning
Hologic's (HOLX) New AI Technology Now Available Post FDA Nod
by Zacks Equity Research
Hologic's (HOLX) latest 3D CAD solution is expected to aid in early detection of breast cancer along with prioritizing the most concerning patient cases.
The Zacks Analyst Blog Highlights: General Motors, L Brands, LH, Hologic and Qorvo
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Motors, L Brands, LH, Hologic and Qorvo
Hill-Rom (HRC) FLC Growth Continues, Surgical Arm Stays Dull
by Zacks Equity Research
Within Front Line Care (FLC), Hill-Rom (HRC) registers growth in vital signs monitoring, blood pressure and thermometry as well as the completion of the U.S. stockpile order for noninvasive ventilators.
Align Technology (ALGN) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Align Technology (ALGN) is optimistic about maintaining a robust product portfolio along with strength in its international business.
Looking for an Earnings Surprise? Play These 5 Stocks
by Sanghamitra Saha
Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.
4 MedTech Stocks Gaining Ground on COVID-19 Test Kit Success
by Debanjana Dey
Here are a few coronavirus-testing MedTech stocks that investors can scoop up to reap profits amid the pandemic-battered stock market situation.
Haemonetics (HAE) New Products Aid, Plasma Sales Remain Tepid
by Zacks Equity Research
Haemonetics (HAE) invests in clinical trials that build evidence for its hemostasis management products.
The Zacks Analyst Blog Highlights: DISH Network, Magna International and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: DISH Network, Magna International and Hologic
NuVasive (NUVA) Launches C360 Portfolio for Cervical Spine
by Zacks Equity Research
The ACP system within NuVasive's (NUVA) C360 portfolio is targeted to reduce common postoperative complications.